This site is only for UK healthcare professionals and contains promotional information.

Prescribing Information can be found at the bottom of this page.

Our high impact tools

At Almirall we have developed a set of dynamic tools to help create alignment and get results fast. Find out how to support local prescribing, understand the costs associated with managing psoriasis and optimise your psoriasis drug spend below.

AlmirallAssist

Discover how to create a compelling business case for prescribing Skilarence® (dimethyl fumarate)

Build here

pathwaypro®

Look at ways to transform your current psoriasis care and treatment pathways

Plan here

Budget Impact Model

Find out how to further optimise your patient care and drug budgets

Budget here

UK-ILU-2100015  March 2021

Sites of interest

Almirall.co.uk

IE-ILU-2300112 July 2023

UK-Adverse events should be reported. Reporting forms and information can be found at MHRA https://yellowcard.mhra.gov.uk or search for MHRA Yellow Card in the Google Play or Apple App Store. Adverse events should also be reported to Almirall Ltd. Tel. 0800 0087 399.

IE-Adverse events should be reported. Reporting forms and information can be found at HPRA Pharmacovigilance, Website: www.hpra.ie. Adverse events should also be reported to Almirall Ltd. Tel. +353 (0) 1431 9836

Prescribing Information

ILUMETRI®▼ (tildrakizumab)

Klisyri®▼ (tirbanibulin)

Skilarence® (dimethyl fumarate)

Wynzora® (calcipotriol and betamethasone dipropionate)

Cookies Policy

Privacy Policy UK

Terms of Use

©2021 Almirall
My Favorites
      No Favorites